课题基金 / 基金详情

TRITIATION OF BETA CYCLODEXTRIN: HEPARIN

TRITIATION OF BETA CYCLODEXTRIN: HEPARIN
β 环糊精的氚化:肝素
批准号:
6220458
负责人:
HIROMI MORIMOTO
金额:
$0.26万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 2000-07-31

项目摘要

项目成果

HIROMI MORIMOTO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A Basic Compositional Requirement of Agents Having Heparin-Like Cell-Modulating Activities Heparin has been recognized as possessing a large variety of cell-modulating activities. Using compositionally simple, structurally rigid, and low molecular weight saccharide molecules (cyclodextrins), we demonstrated that these activities depend primarily on a single, gross compositional parameter: a minimum intramolecular density of neighboring anionic (sulfate) groups. This same critical parameter is shown to be involved in achieving cell-modulating behaviors as diverse as angiogenesis, endothelial proliferation, inhibition of smooth muscle cell growth, and cell protection against virus invasion. Physical chemical evidence is presented that associates this property with multi-ionic complex formation between the clusters of anionic and cationic sites on the complexing partners. These observations revive early suggestions of the decisive role of electrostatic complexation capabilities of glycosaminoglycans like heparin. Taken together with numerous observations on hepatinoids and other agents reported in diverse specialized fields of cell biology and medicine, they provide evidence that molecular agents of critical anionic (sulfate) density (MACADs) represent a broad class of molecules that, in contrast to proteins, do not rely on structural detail for their cell biological activities, but function by ionic complexation with proteinic agents (e.g. growth factors), thereby modifying their structure specific activities. Tritium labelling of these materials will greatly facilitate studies of the mechanism of action. A first attempt at labelling by metal-catalyzed exchange into the final molecule was unsuccessful. As a second approach, a precursor suitable for hydride reduction is being prepared, and we expect to carry out those reactions during the coming grant period.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TRITIUM LABELLING OF APTAMERS: MACULAR DEGENERATION
SYNTHESIS OF SPECIFICALLY LABELLED NICOTINE COMPOUND: PARKINSON'S & ALZHEIMER'S
STEREOCHEMISTRY OF POLYKETIDE BIOSYNTHESIS
TRITIUM LABELLING OF ALZHEIMER DRUG
海外基金